Evidence map›Paper›PMID 26848777›Full record

ArticleOncotarget2016

Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57.

Mengjie Wang, Qi Dong, Hua Wang, Yaqing He, Ying Chen, Hong Zhang, Rong Wu, Xinchun Chen, Boping Zhou, Jason He and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Targeted Dereplication ofMolecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Mengjie WangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Qi DongShenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.
Hua WangStanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.
Yaqing HeShenzhen Center for Disease Control and Prevention (Shenzhen CDC), Shenzhen, China.
Ying ChenDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Hong ZhangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Rong WuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xinchun ChenInstitute of Infectious Diseases, The 3rd Peoples' Hospital of Shenzhen, Shenzhen, China.
Boping ZhouInstitute of Infectious Diseases, The 3rd Peoples' Hospital of Shenzhen, Shenzhen, China.
Jason HeCollege of Letter and Sciences, University of California at Berkeley, Berkeley, CA, USA.
Hsiang-Fu KungShenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.
Canhua HuangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yuquan WeiState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Jian-dong HuangSchool of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.
Hongxi XuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ming-Liang HeDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
City University of Hong Kong · HKShanghai University of Traditional Chinese Medicine · CNChinese University of Hong Kong, Shenzhen · CNShenzhen Third People’s Hospital · CNState Key Laboratory of BiotherapyBerkeley College · USChinese University of Hong Kong · CNShenzhen Center for Disease Control and Prevention · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is no effective drug to treat EV71 infection yet. Traditional Chinese herbs are great resources for novel antiviral compounds. Here we showed that Oblongifolin M (OM), an active compound isolated from Garcinia oblongifolia, potently inhibited EV71 infection in a dose dependent manner. To identify its potential effectors in the host cells, we successfully identified 18 proteins from 52 differentially expressed spots by comparative proteomics studies. Further studies showed that knockdown of ERp57 inhibited viral replication through downregulating viral IRES (internal ribosome entry site) activities, whereas ectopic expression of ERp57 increased IRES activity and partly rescued the inhibitory effects of OM on viral replication. We demonstrated that OM is an effective antiviral agent; and that ERp57 is one of its cellular effectors against EV71 infection.

Indexed as

Antiviral AgentsBlotting, WesternElectrophoresis, Gel, Two-DimensionalEnterovirus A, HumanEnterovirus InfectionsGarciniaGenome, ViralHumansPlant ExtractsProtein Disulfide-IsomerasesProteomicsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRhabdomyosarcomaRNA, MessengerRNA, Small InterferingAntiviral AgentsPDIA3 protein, humanPlant ExtractsProtein Disulfide-IsomerasesRNA, MessengerRNA, Small InterferingRNA, ViralTerpenesViral Proteinsantiviralenterovirus 71ERp57Oblongifolin M

Identifiers

PMID26848777
PMCPMC4891005
OpenAlexW2287593267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.